PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2360.0
(0.0%)
IDR 2360.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 688.49 Billion IDR | -18.76% |
| 2022 | 847.53 Billion IDR | -0.04% |
| 2021 | 847.88 Billion IDR | 24.58% |
| 2020 | 680.59 Billion IDR | 17.22% |
| 2019 | 580.62 Billion IDR | -11.09% |
| 2018 | 653.06 Billion IDR | 26.15% |
| 2017 | 517.67 Billion IDR | -6.9% |
| 2016 | 556.02 Billion IDR | 1.63% |
| 2015 | 547.12 Billion IDR | 7.15% |
| 2014 | 510.6 Billion IDR | 9.97% |
| 2013 | 464.31 Billion IDR | 15.29% |
| 2012 | 402.75 Billion IDR | 14.73% |
| 2011 | 351.04 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 221.14 Billion IDR | 152.61% |
| 2024 Q1 | 278.93 Billion IDR | 88.33% |
| 2024 Q2 | 87.54 Billion IDR | -68.61% |
| 2023 Q3 | 194.15 Billion IDR | 155.72% |
| 2023 FY | 688.49 Billion IDR | -18.76% |
| 2023 Q1 | 270.31 Billion IDR | 53.49% |
| 2023 Q2 | 75.92 Billion IDR | -71.91% |
| 2023 Q4 | 148.1 Billion IDR | -23.72% |
| 2022 Q1 | 263.37 Billion IDR | 52.82% |
| 2022 FY | 847.53 Billion IDR | -0.04% |
| 2022 Q4 | 176.1 Billion IDR | -25.88% |
| 2022 Q3 | 237.61 Billion IDR | 39.42% |
| 2022 Q2 | 170.43 Billion IDR | -35.29% |
| 2021 Q3 | 260.35 Billion IDR | 41.92% |
| 2021 Q2 | 183.45 Billion IDR | -20.82% |
| 2021 Q4 | 172.34 Billion IDR | -33.8% |
| 2021 Q1 | 231.71 Billion IDR | -5.13% |
| 2021 FY | 847.88 Billion IDR | 24.58% |
| 2020 Q1 | 175.83 Billion IDR | 60.32% |
| 2020 FY | 680.59 Billion IDR | 17.22% |
| 2020 Q2 | 146.21 Billion IDR | -16.84% |
| 2020 Q3 | 114.3 Billion IDR | -21.83% |
| 2020 Q4 | 244.23 Billion IDR | 113.67% |
| 2019 FY | 580.62 Billion IDR | -11.09% |
| 2019 Q3 | 156.73 Billion IDR | -13.95% |
| 2019 Q4 | 109.67 Billion IDR | -30.02% |
| 2019 Q1 | 132.08 Billion IDR | -28.08% |
| 2019 Q2 | 182.13 Billion IDR | 37.9% |
| 2018 Q2 | 169.45 Billion IDR | 47.59% |
| 2018 Q1 | 114.81 Billion IDR | -36.2% |
| 2018 Q4 | 183.63 Billion IDR | -0.82% |
| 2018 FY | 653.06 Billion IDR | 26.15% |
| 2018 Q3 | 185.14 Billion IDR | 9.26% |
| 2017 Q2 | 154.02 Billion IDR | 71.08% |
| 2017 FY | 517.67 Billion IDR | -6.9% |
| 2017 Q4 | 179.97 Billion IDR | 92.21% |
| 2017 Q3 | 93.63 Billion IDR | -39.21% |
| 2017 Q1 | 90.03 Billion IDR | -49.7% |
| 2016 Q4 | 179 Billion IDR | 56.69% |
| 2016 FY | 556.02 Billion IDR | 1.63% |
| 2016 Q3 | 114.24 Billion IDR | -18.15% |
| 2016 Q2 | 139.57 Billion IDR | 13.28% |
| 2016 Q1 | 123.2 Billion IDR | -22.45% |
| 2015 FY | 547.12 Billion IDR | 7.15% |
| 2015 Q4 | 158.86 Billion IDR | -2.08% |
| 2015 Q3 | 162.23 Billion IDR | 24.25% |
| 2015 Q2 | 130.57 Billion IDR | 36.82% |
| 2015 Q1 | 95.44 Billion IDR | -38.67% |
| 2014 FY | 510.6 Billion IDR | 9.97% |
| 2014 Q4 | 155.61 Billion IDR | 14.57% |
| 2014 Q3 | 135.82 Billion IDR | 1.87% |
| 2014 Q2 | 133.33 Billion IDR | 55.35% |
| 2014 Q1 | 85.83 Billion IDR | -50.71% |
| 2013 Q4 | 174.15 Billion IDR | 141.39% |
| 2013 FY | 464.31 Billion IDR | 15.29% |
| 2013 Q1 | 79.42 Billion IDR | -46.86% |
| 2013 Q2 | 138.58 Billion IDR | 74.48% |
| 2013 Q3 | 72.14 Billion IDR | -47.94% |
| 2012 Q1 | 76.34 Billion IDR | 0.0% |
| 2012 FY | 402.75 Billion IDR | 14.73% |
| 2012 Q3 | 91.95 Billion IDR | 8.19% |
| 2012 Q4 | 149.46 Billion IDR | 62.55% |
| 2012 Q2 | 84.99 Billion IDR | 11.34% |
| 2011 FY | 351.04 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 5.19 Billion IDR | -13144.378% |
| PT Kimia Farma (Persero) Tbk | -1485.56 Billion IDR | 146.346% |
| PT Millennium Pharmacon International Tbk | 33.08 Billion IDR | -1980.84% |
| PT Soho Global Health Tbk | 371.34 Billion IDR | -85.409% |